Bacopa monniera: A Promising Phytotherapeutic Approach in Management of Diabetes-Related Complications

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia due to impaired insulin secretion and/or action. Prolonged and severe DM often leads to debilitating complications, including diabetic neuropathy (DN), retinopathy (DR), nephropathy (DNP), and cardiomyopathy. Several studies have demonstrated that overwhelming oxidative stress, chronic inflammatory responses, and mitochondrial dysfunction are major contributors to these underlying diabetes-related complications. Current therapeutic strategies, including insulin intake and use of oral hypoglycemics, often fail to prevent or reduce the progression of microvascular and neurodegenerative complications, thus warranting an alternative, multi-targeted intervention. Bacopa monniera (BM), a traditional medicinal herb rich in bacosides, saponins, and flavonoids, has demonstrated potent antioxidant, anti-inflammatory, and neuroprotective effects in preclinical models. However, comprehensive evaluations of BM efficacy across multiple diabetes-related complications and mechanistic pathways remain limited. This review consolidates current evidence on the role of BM in mitigating diabetes-related complications, emphasizing its ability to alleviate oxidative stress, suppress pro-inflammatory cytokine response, preserve mitochondrial integrity, and protect neuronal and vascular structural integrity. By bridging existing gaps in the literature, this work highlights BM as a promising phytotherapeutic drug in diabetes management, especially for combating the metabolic and neurovascular complications in severe DM.